REDW — Redwood Pharma AB Share Price
0.000.00%
Last trade - 00:00- SEK20.64m
- SEK19.82m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.04 | ||
| Price to Tang. Book | 15.51 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -126.84% | ||
| Return on Equity | -121.24% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Redwood Pharma AB is a Sweden-based company, which is primarily focused on pharmaceutical industry. The Company develops IntelliGel, a patented hydrogel drug delivery platform technology. IntelliGel is a patented supramolecular smart drug delivery system with an ability to dissolve water-insoluble and sparingly soluble drugs, or disperse, suspend and stabilize otherwise insoluble drugs. It is an odor-free, clear and transparent hydrogel with low solid content, and forms an invisible patch when applied to a surface. The Company’s development product is focused on treatment of chronic Dry Eye Disease (DED) in post-menopausal women. It is based on a naturally occurring, endogenous molecule found in the body.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- February 23rd, 2012
- Public Since
- June 15th, 2016
- No. of Employees
- 1
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 21,231,000
- Address
- Ringvagen 100 E 9Th Floor, STOCKHOLM, 11860
- Web
- https://redwoodpharma.se/
- Phone
- Auditors
- Finnhammars Revisionsbyra
Upcoming Events for REDW
Redwood Pharma AB Annual Shareholders Meeting
Similar to REDW
Biogaia AB
OMX Nordic Exchange Stockholm
BoneSupport Holding AB
OMX Nordic Exchange Stockholm
Calliditas Therapeutics AB
OMX Nordic Exchange Stockholm
Camurus AB
OMX Nordic Exchange Stockholm
Cinclus Pharma Holding publ AB
OMX Nordic Exchange Stockholm
FAQ
What is the Redwood Pharma AB share price?
As of Today at 22:55 UTC, shares in Redwood Pharma AB are trading at SEK2.90. This share price information is delayed by 15 minutes.
How has the Redwood Pharma AB share price performed this year?
Shares in Redwood Pharma AB last closed at SEK2.90 and the price had moved by -90.16% over the past 365 days. In terms of relative price strength the Redwood Pharma AB share price has underperformed the FTSE Global All Cap Index by -91.35% over the past year.
What are the analyst and broker recommendations for Redwood Pharma AB?
There is no consensus recommendation for this security.
What is the Redwood Pharma AB dividend yield?
Redwood Pharma AB does not currently pay a dividend.
Does Redwood Pharma AB pay a dividend?
Redwood Pharma AB does not currently pay a dividend.
When does Redwood Pharma AB next pay dividends?
Redwood Pharma AB does not currently pay a dividend.
How do I buy Redwood Pharma AB shares?
To buy shares in Redwood Pharma AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Redwood Pharma AB?
As of the previous close price of SEK2.90, shares in Redwood Pharma AB had a market capitalisation of SEK61.57m.
Where are Redwood Pharma AB shares listed?
Here are the trading details for Redwood Pharma AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: REDW
What kind of share is Redwood Pharma AB?
Based on an overall assessment of its quality, value and momentum Redwood Pharma AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Redwood Pharma AB share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Redwood Pharma AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Redwood Pharma AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -32.76%.
As of the last closing price of SEK2.90, shares in Redwood Pharma AB were trading -9.83% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Redwood Pharma AB PE Ratio?
The Redwood Pharma AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK2.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Redwood Pharma AB?
We do not have data on Redwood Pharma AB's directors